XNAS 19 May, 2026 9:35 AM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 2.34 per share. | 04 May 2026 | 264 | 506,997 | - | 2.3 | 618 | Common Stock |
| Chad Cowan | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.19 per share. | 01 Apr 2026 | 1,365 | 1,175,680 | - | 2.2 | 2,989 | Common Stock |
| Gregory Russotti | See Remarks | Sale of securities on an exchange or to another person at price $ 2.55 per share. | 12 Mar 2026 | 10,076 | 515,427 | - | 2.5 | 25,684 | Common Stock |
| Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 2.55 per share. | 12 Mar 2026 | 7,043 | 507,261 | - | 2.5 | 17,953 | Common Stock |
| Brent Pfeiffenberger | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.73 per share. | 11 Mar 2026 | 55,397 | 3,710,958 | - | 2.7 | 151,234 | Common Stock |
| Chad Cowan | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.73 per share. | 11 Mar 2026 | 1,431 | 1,177,045 | - | 2.7 | 3,907 | Common Stock |
| Gregory Russotti | See Remarks | Sale of securities on an exchange or to another person at price $ 2.54 per share. | 09 Mar 2026 | 479 | 525,503 | - | 2.5 | 1,215 | Common Stock |
| Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 2.53 per share. | 09 Mar 2026 | 247 | 514,304 | - | 2.5 | 626 | Common Stock |
| Brent Pfeiffenberger | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.56 per share. | 06 Mar 2026 | 463 | 3,766,355 | - | 2.6 | 1,185 | Common Stock |
| Brent Pfeiffenberger | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.75 per share. | 13 Feb 2026 | 31,172 | 3,766,818 | - | 1.8 | 54,551 | Common Stock |
| Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 1.82 per share. | 03 Feb 2026 | 323 | 514,551 | - | 1.8 | 589 | Common Stock |
| Gregory Russotti | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 135,000 | 525,982 | - | 0 | Common Stock | |
| Gregory Russotti | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 265,000 | 265,000 | - | - | Stock Option (right to buy) | |
| Douglas Carr | SVP Finance & Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 225,000 | 225,000 | - | - | Stock Option (right to buy) | |
| Douglas Carr | SVP Finance & Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 110,000 | 514,874 | - | 0 | Common Stock | |
| Brent Pfeiffenberger | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 945,000 | 945,000 | - | - | Stock Option (right to buy) | |
| Brent Pfeiffenberger | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 475,000 | 3,797,990 | - | 0 | Common Stock | |
| Chad Cowan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 135,000 | 1,178,476 | - | 0 | Common Stock | |
| Chad Cowan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 265,000 | 265,000 | - | - | Stock Option (right to buy) | |
| Chad Cowan | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.00 per share. | 02 Jan 2026 | 1,611 | 1,043,476 | - | 1.0 | 1,603 | Common Stock |
| Chad Cowan | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 22 Dec 2025 | 58,060 | 1,045,087 | - | 0.8 | 49,252 | Common Stock |
| Brent Pfeiffenberger | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.58 per share. | 12 Dec 2025 | 52,000 | 3,322,990 | - | 0.6 | 30,352 | Common Stock |
| Brent Pfeiffenberger | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.53 per share. | 10 Dec 2025 | 463 | 3,270,990 | - | 0.5 | 244 | Common Stock |
| Han Myung Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2025 | 88,000 | 88,000 | - | - | Stock Option (right to buy) | |
| Martin Patrick Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2025 | 88,000 | 88,000 | - | - | Stock Option (right to buy) | |
| Gregory Russotti | See Remarks | Sale of securities on an exchange or to another person at price $ 0.53 per share. | 08 Dec 2025 | 526 | 390,982 | - | 0.5 | 280 | Common Stock |
| Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.53 per share. | 08 Dec 2025 | 257 | 404,874 | - | 0.5 | 137 | Common Stock |
| Chad Cowan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 0.50 per share. | 20 Nov 2025 | 5,462 | 987,027 | - | 0.5 | 2,736 | Common Stock |
| Brent Pfeiffenberger | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.50 per share. | 19 Nov 2025 | 35,000 | 3,271,453 | - | 0.5 | 17,329 | Common Stock |
| Brent Pfeiffenberger | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.45 per share. | 17 Nov 2025 | 32,456 | 3,236,453 | - | 0.5 | 14,735 | Common Stock |
| Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 03 Nov 2025 | 292 | 405,131 | - | 0.6 | 171 | Common Stock |
| Chad Cowan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2025 | 762,543 | 992,489 | - | 0 | Common Stock | |
| Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.50 per share. | 08 Sep 2025 | 263 | 405,423 | - | 0.5 | 132 | Common Stock |
| Gregory Russotti | See Remarks | Sale of securities on an exchange or to another person at price $ 0.50 per share. | 08 Sep 2025 | 539 | 391,508 | - | 0.5 | 270 | Common Stock |
| Brent Pfeiffenberger | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.50 per share. | 08 Sep 2025 | 488 | 3,268,909 | - | 0.5 | 244 | Common Stock |
| Brent Pfeiffenberger | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2025 | 1,587,614 | 3,269,397 | - | 0 | Common Stock | |
| Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.53 per share. | 04 Aug 2025 | 296 | 405,686 | - | 0.5 | 158 | Common Stock |
| Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Timothy P. Walbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Daphne Quimi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Kimberly L. Blackwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Carlo Rizzuto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Alessandro Riva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 09 Jun 2025 | 552 | 250,141 | - | 0.6 | 343 | Common Stock |
| Gregory Russotti | See Remarks | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 09 Jun 2025 | 526 | 392,047 | - | 0.6 | 327 | Common Stock |
| Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 09 Jun 2025 | 4,904 | 405,982 | - | 0.6 | 3,050 | Common Stock |
| Brent Pfeiffenberger | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 09 Jun 2025 | 475 | 1,681,783 | - | 0.6 | 295 | Common Stock |
| Brent Pfeiffenberger | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.55 per share. | 16 May 2025 | 29,552 | 1,682,258 | - | 0.5 | 16,135 | Common Stock |
| Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 0.55 per share. | 05 May 2025 | 1,024 | 250,693 | - | 0.5 | 563 | Common Stock |
| Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.55 per share. | 05 May 2025 | 295 | 410,886 | - | 0.5 | 162 | Common Stock |
| Morgan Conn | Chief Finanical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 19,500 | 79,648 | - | 0 | Common Stock | |
| Morgan Conn | Chief Finanical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | |
| Chad Cowan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | |
| Chad Cowan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 19,500 | 230,306 | - | 0 | Common Stock | |
| Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 120,000 | 251,717 | - | 0 | Common Stock | |
| Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 10 Mar 2025 | 2,359 | 131,717 | - | 0.6 | 1,451 | Common Stock |
| Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 120,000 | 120,000 | - | - | Stock Option (right to buy) | |
| Gregory Russotti | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 120,000 | 392,573 | - | 0 | Common Stock | |
| Gregory Russotti | See Remarks | Sale of securities on an exchange or to another person at price $ 0.61 per share. | 10 Mar 2025 | 2,360 | 272,573 | - | 0.6 | 1,451 | Common Stock |
| Gregory Russotti | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 120,000 | 120,000 | - | - | Stock Option (right to buy) | |
| Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 10 Mar 2025 | 1,240 | 315,556 | - | 0.6 | 763 | Common Stock |
| Douglas Carr | SVP Finance & Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 95,625 | 95,625 | - | - | Stock Option (right to buy) | |
| Douglas Carr | SVP Finance & Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 95,625 | 411,181 | - | 0 | Common Stock | |
| Brent Pfeiffenberger | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 10 Mar 2025 | 2,235 | 1,190,310 | - | 0.6 | 1,375 | Common Stock |
| Brent Pfeiffenberger | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 521,500 | 1,711,810 | - | 0 | Common Stock | |
| Brent Pfeiffenberger | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 521,500 | 521,500 | - | - | Stock Option (right to buy) | |
| Brent Pfeiffenberger | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 18 Feb 2025 | 34,712 | 1,192,545 | - | 0.8 | 27,179 | Common Stock |
| Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 03 Feb 2025 | 1,054 | 134,076 | - | 0.8 | 822 | Common Stock |
| Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 03 Feb 2025 | 351 | 316,796 | - | 0.8 | 274 | Common Stock |
| Brent Pfeiffenberger | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.44 per share. | 04 Dec 2024 | 243,447 | 1,227,257 | - | 1.4 | 350,564 | Common Stock |
| Adrienne Farid | Chief Operations Officer | 04 Nov 2024 | 1,033 | 135,130 | - | 1.2 | 1,267 | Common Stock | |
| Douglas Carr | SVP Finance & Operations | 01 Nov 2024 | 283 | 317,147 | - | 1.2 | 347 | Common Stock | |
| Douglas Carr | SVP Finance & Operations | 01 Nov 2024 | 16,611 | 317,430 | - | 1.3 | 20,930 | Common Stock | |
| Morgan Conn | Chief Finanical Officer | 14 Oct 2024 | 60,148 | 60,148 | - | 0 | Common Stock | ||
| Morgan Conn | Chief Finanical Officer | 14 Oct 2024 | 360,890 | 360,890 | - | - | Stock Option (right to buy) | ||
| Chad Cowan | Chief Scientific Officer | 01 Oct 2024 | 446,250 | 446,250 | - | - | Stock Option (right to buy) | ||
| Chad Cowan | Chief Scientific Officer | 01 Oct 2024 | 74,376 | 210,806 | - | 0 | Common Stock | ||
| Daphne Quimi | Director | Purchase of securities on an exchange or from another person at price $ 1.53 per share. | 12 Sep 2024 | 5,000 | 5,000 | - | 1.5 | 7,657 | Common Stock |
| Adrienne Farid | Chief Operations Officer | 05 Aug 2024 | 1,073 | 136,163 | - | 1.8 | 1,960 | Common Stock | |
| Douglas Carr | SVP Finance & Operations | 05 Aug 2024 | 289 | 334,041 | - | 1.8 | 528 | Common Stock | |
| Gregory Russotti | See Remarks | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 26 Jul 2024 | 586 | 274,933 | - | 2.5 | 1,465 | Common Stock |
| Gregory Russotti | See Remarks | Sale of securities on an exchange or to another person at price $ 2.52 per share. | 23 Jul 2024 | 1,600 | 275,519 | - | 2.5 | 4,029 | Common Stock |
| Gregory Russotti | See Remarks | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 23 Jul 2024 | 200 | 277,119 | - | 2.5 | 500 | Common Stock |
| Cynthia M. Butitta | Director | 20 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | ||
| Joseph Jimenez | Director | 20 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | ||
| Timothy P. Walbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Daphne Quimi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Kimberly L. Blackwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Carlo Rizzuto | Director | 20 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | ||
| Alessandro Riva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Gregory Russotti | See Remarks | Sale of securities on an exchange or to another person at price $ 2.84 per share. | 20 Jun 2024 | 5,000 | 277,319 | - | 2.8 | 14,179 | Common Stock |
| Douglas Carr | SVP Finance & Operations | 07 Jun 2024 | 17,007 | 334,330 | - | 0 | Common Stock | ||
| Gregory Russotti | See Remarks | Sale of securities on an exchange or to another person at price $ 3.00 per share. | 05 Jun 2024 | 5,000 | 282,319 | - | 3.0 | 14,989 | Common Stock |
| Gregory Russotti | See Remarks | Sale of securities on an exchange or to another person at price $ 3.00 per share. | 20 May 2024 | 5,000 | 287,319 | - | 3.0 | 14,978 | Common Stock |
| Gregory Russotti | See Remarks | Sale of securities on an exchange or to another person at price $ 3.12 per share. | 06 May 2024 | 5,000 | 292,319 | - | 3.1 | 15,619 | Common Stock |
| Adrienne Farid | Chief Operations Officer | 03 May 2024 | 913 | 137,236 | - | 3.1 | 2,836 | Common Stock | |
| Douglas Carr | SVP Finance & Operations | 03 May 2024 | 257 | 317,323 | - | 3.1 | 798 | Common Stock | |
| Gregory Russotti | See Remarks | Sale of securities on an exchange or to another person at price $ 3.10 per share. | 22 Apr 2024 | 5,000 | 297,319 | - | 3.1 | 15,490 | Common Stock |
| Hyam I. Levitsky | President of R&D | 07 Mar 2024 | 146,000 | 146,000 | - | - | Stock Option (right to buy) | ||
| Hyam I. Levitsky | President of R&D | 07 Mar 2024 | 24,000 | 24,000 | - | 0 | Common Stock | ||
| Adrienne Farid | Chief Operations Officer | 07 Mar 2024 | 24,000 | 138,149 | - | 0 | Common Stock | ||
| Adrienne Farid | Chief Operations Officer | 07 Mar 2024 | 146,000 | 146,000 | - | - | Stock Option (right to buy) | ||
| Gregory Russotti | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 24,000 | 302,319 | - | 0 | Common Stock | |
| Gregory Russotti | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 146,000 | 146,000 | - | - | Stock Option (right to buy) | |
| Douglas Carr | SVP Finance & Operations | 07 Mar 2024 | 14,000 | 317,580 | - | 0 | Common Stock | ||
| Douglas Carr | SVP Finance & Operations | 07 Mar 2024 | 81,000 | 81,000 | - | - | Stock Option (right to buy) | ||
| Brent Pfeiffenberger | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 17,425 | 1,470,704 | - | 0 | Common Stock | |
| Brent Pfeiffenberger | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 104,550 | 104,550 | - | - | Stock Option (right to buy) | |
| Adrienne Farid | Chief Operations Officer | 06 Mar 2024 | 22,831 | 136,980 | - | 1.0 | 23,516 | Common Stock | |
| Adrienne Farid | Chief Operations Officer | 06 Mar 2024 | 30,684 | 144,833 | - | 1.0 | 31,605 | Common Stock | |
| Adrienne Farid | Chief Operations Officer | 06 Mar 2024 | 30,684 | 114,149 | - | 5.0 | 152,340 | Common Stock | |
| Adrienne Farid | Chief Operations Officer | 06 Mar 2024 | 22,831 | 114,149 | - | 5.1 | 117,342 | Common Stock | |
| Adrienne Farid | Chief Operations Officer | 06 Mar 2024 | 22,831 | 168,655 | - | - | Stock Option (right to buy) | ||
| Adrienne Farid | Chief Operations Officer | 06 Mar 2024 | 30,684 | 191,486 | - | - | Stock Option (right to buy) | ||
| Farid Adrienne | Chief Operations Officer | 16 Feb 2024 | 485 | 222,170 | - | - | Stock Option (right to buy) | ||
| Adrienne Farid | Chief Operations Officer | 16 Feb 2024 | 485 | 114,634 | - | 1.0 | 500 | Common Stock | |
| Adrienne Farid | Chief Operations Officer | 16 Feb 2024 | 485 | 114,149 | - | 4.9 | 2,358 | Common Stock | |
| Carr Douglas | SVP Finance & Operations | 05 Feb 2024 | 643 | 304,137 | - | 3.8 | 2,470 | Common Stock | |
| Douglas Carr | SVP Finance & Operations | 05 Feb 2024 | 557 | 303,580 | - | 4.5 | 2,499 | Common Stock | |
| Farid Adrienne | Chief Operations Officer | 05 Feb 2024 | 2,035 | 115,933 | - | 3.8 | 7,816 | Common Stock | |
| Adrienne Farid | Chief Operations Officer | 05 Feb 2024 | 1,784 | 114,149 | - | 4.5 | 8,005 | Common Stock | |
| Brent Pfeiffenberger | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 573,691 | 573,691 | - | - | Stock Option (right to buy) | |
| Brent Pfeiffenberger | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 279,504 | 1,453,279 | - | 0 | Common Stock | |
| Pfeiffenberger Brent | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 1,173,775 | 1,173,775 | - | 0 | Common Stock | |
| Cynthia M. Butitta | Director | 27 Jun 2023 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | ||
| Joseph Jimenez | Director | 27 Jun 2023 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | ||
| Timothy P. Walbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Daphne Quimi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Kimberly Blackwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Carlo Rizzuto | Director | 27 Jun 2023 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | ||
| Alessandro Riva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Michael Diem | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 151,058 | 274,296 | - | 0 | Common Stock | |
| Douglas Carr | SVP Finance & Operations | 15 May 2023 | 120,846 | 321,391 | - | 0 | Common Stock | ||
| Gregory Russotti | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2023 | 318,750 | 318,750 | - | - | Stock Option (right to buy) | |
| Luis Borges | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 7,452 | 0 | - | - | Stock Option (right to buy) | |
| Luis Borges | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 03 Apr 2023 | 7,452 | 256,535 | - | 1.0 | 7,676 | Common Stock |
| Luis Borges | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 3.55 per share. | 21 Mar 2023 | 15,597 | 249,083 | - | 3.5 | 55,369 | Common Stock |
| Luis Borges | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 21 Mar 2023 | 63,616 | 107,366 | - | 1.0 | 65,524 | Common Stock |
| Luis Borges | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 3.77 per share. | 21 Mar 2023 | 63,616 | 43,750 | - | 3.8 | 239,870 | Common Stock |
| Luis Borges | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 21 Mar 2023 | 65,698 | 109,448 | - | 1.0 | 67,669 | Common Stock |
| Luis Borges | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 3.72 per share. | 21 Mar 2023 | 65,698 | 43,750 | - | 3.7 | 244,640 | Common Stock |
| Luis Borges | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 21 Mar 2023 | 220,930 | 264,680 | - | 1.0 | 227,558 | Common Stock |
| Luis Borges | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2023 | 63,616 | 294,080 | - | - | Stock Option (right to buy) | |
| Luis Borges | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2023 | 65,698 | 228,382 | - | - | Stock Option (right to buy) | |
| Luis Borges | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2023 | 220,930 | 7,452 | - | - | Stock Option (right to buy) | |
| Michael Diem | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 131,250 | 131,250 | - | - | Stock Option (right to buy) | |
| Michael Diem | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 131,250 | 131,250 | - | - | Stock Option (right to buy) | |
| Michael Diem | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 21,875 | 123,238 | - | 0 | Common Stock | |
| Michael Diem | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 21,875 | 101,363 | - | 0 | Common Stock | |
| Luis Borges | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 21,875 | 43,750 | - | 0 | Common Stock | |
| Luis Borges | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 131,250 | 131,250 | - | - | Stock Option (right to buy) | |
| Luis Borges | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 131,250 | 131,250 | - | - | Stock Option (right to buy) | |
| Luis Borges | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 21,875 | 21,875 | - | 0 | Common Stock | |
| Osvaldo Flores | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 637,500 | 637,500 | - | - | Stock Option (right to buy) | |
| Osvaldo Flores | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 637,500 | 637,500 | - | - | Stock Option (right to buy) | |
| Adrienne Farid | Chief Operations Officer | 02 Feb 2023 | 131,250 | 131,250 | - | - | Stock Option (right to buy) | ||
| Adrienne Farid | Chief Operations Officer | 02 Feb 2023 | 21,875 | 96,093 | - | 0 | Common Stock | ||
| Adrienne Farid | Chief Operations Officer | 02 Feb 2023 | 21,875 | 117,968 | - | 0 | Common Stock | ||
| Adrienne Farid | Chief Operations Officer | 02 Feb 2023 | 131,250 | 131,250 | - | - | Stock Option (right to buy) | ||
| Gregory Russotti | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 175,000 | 175,000 | - | - | Stock Option (right to buy) | |
| Gregory Russotti | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 175,000 | 175,000 | - | - | Stock Option (right to buy) | |
| Douglas Carr | VP Finance & Operations | 02 Feb 2023 | 7,500 | 200,545 | - | 0 | Common Stock | ||
| Douglas Carr | VP Finance & Operations | 02 Feb 2023 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | ||
| Douglas Carr | VP Finance & Operations | 02 Feb 2023 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | ||
| Douglas Carr | VP Finance & Operations | 02 Feb 2023 | 7,500 | 193,045 | - | 0 | Common Stock | ||
| Timothy P. Walbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 39,744 | 39,744 | - | - | Stock Option (right to buy) | |
| Daphne Quimi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 39,744 | 39,744 | - | - | Stock Option (right to buy) | |
| Cynthia M. Butitta | Director | 09 Jun 2022 | 19,872 | 19,872 | - | - | Stock Option (right to buy) | ||
| Joseph Jimenez | Director | 09 Jun 2022 | 19,872 | 19,872 | - | - | Stock Option (right to buy) | ||
| Eli D. Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 19,872 | 19,872 | - | - | Stock Option (right to buy) | |
| Kimberly Blackwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 19,872 | 19,872 | - | - | Stock Option (right to buy) | |
| Carlo Rizzuto | Director | 09 Jun 2022 | 19,872 | 19,872 | - | - | Stock Option (right to buy) | ||
| Alessandro Riva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 19,872 | 19,872 | - | - | Stock Option (right to buy) | |
| Hyam I. Levitsky | President of R&D | 25 Jan 2022 | 105,000 | 105,000 | - | - | Stock Option (right to buy) | ||
| Michael Diem | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 105,000 | 105,000 | - | - | Stock Option (right to buy) | |
| Luis Borges | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 105,000 | 105,000 | - | - | Stock Option (right to buy) | |
| Osvaldo Flores | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 315,000 | 315,000 | - | - | Stock Option (right to buy) | |
| Adrienne Farid | Chief Operations Officer | 25 Jan 2022 | 105,000 | 105,000 | - | - | Stock Option (right to buy) | ||
| Gregory Russotti | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 105,000 | 105,000 | - | - | Stock Option (right to buy) | |
| Douglas Carr | VP of Finance and Operations | 25 Jan 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | ||
| Eli Casdin | Director | 22 Jun 2021 | 6,180,500 | 0 | - | - | Series C Preferred Stock | ||
| Eli Casdin | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 22 Jun 2021 | 750,000 | 3,206,380 | - | 20 | 15,000,000 | Common Stock |
| Eli Casdin | Director | 22 Jun 2021 | 2,456,380 | 2,456,380 | - | - | Common Stock | ||
| Cynthia M. Butitta | Director | 17 Jun 2021 | 19,872 | 19,872 | - | - | Option (right to buy) | ||
| Joseph Jimenez | Director | 17 Jun 2021 | 19,872 | 19,872 | - | - | Option (right to buy) | ||
| Eli Casdin | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2021 | 39,744 | 39,744 | - | - | Option (right to buy) | |
| Kimberly Blackwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 19,872 | 19,872 | - | - | Option (right to buy) | |
| Carlo Rizzuto | Director | 17 Jun 2021 | 39,744 | 39,744 | - | - | Option (right to buy) | ||
| Alessandro Riva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 19,872 | 19,872 | - | - | Option (right to buy) |